A colorimetric assay for 7-dehydrocholesterol with potential application to screening for Smith-Lemli-Opitz syndrome

Chemistry and Physics of Lipids

Volumn 115, Issue 1-2, 2002, Pages 1-15

  Xiong, Quanbo ^a   Ruan, Benfang ^a   Whitby, Frank G ^b   Tuohy, Richard P ^b   Belanger, Thomas L ^a   Kelley, Richard I ^c   Wilson, William K ^a   Schroepfer Jr , George J ^a  

^a RICE UNIVERSITY   (United States)

^b UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

^c JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

7 Dehydrocholesterol; Diagnostic testing; Guthrie card; Liebermann Burchard reagent; Neonatal screening; NMR; SLOS

Indexed keywords

7 DEHYDROCHOLESTEROL; 7 DEHYDROCHOLESTEROL REDUCTASE; ANTIOXIDANT; OXIDOREDUCTASE; REAGENT; UNCLASSIFIED DRUG;

ARTICLE; BLOOD SAMPLING; COLORIMETRY; CONTROLLED STUDY; DEVICE; DIAGNOSTIC PROCEDURE; GENETIC DISORDER; HUMAN; HYPOCHOLESTEROLEMIA; LOW TEMPERATURE; MUTATION; PRIORITY JOURNAL; SMITH LEMLI OPITZ SYNDROME;

CASE-CONTROL STUDIES; COLORIMETRY; DEHYDROCHOLESTEROLS; HUMANS; INDICATORS AND REAGENTS; KINETICS; NUCLEAR MAGNETIC RESONANCE, BIOMOLECULAR; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; SMITH-LEMLI-OPITZ SYNDROME;

EID: 0036275403     PISSN: 00093084     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0009-3084(01)00205-5     Document Type: Article

References (46)

1. Simplified method for the estimation of total cholesterol in serum and demonstration of its specificity
2. Smith-Lemli-Opitz syndrome: The first malformation syndrome associated with defective cholesterol synthesis
3. A simple PCR-based assay allows detection of a common mutation, IVS8-1G→C, in DHCR7 in Smith-Lemli-Opitz syndrome
4. Carrier frequency of the common mutation IVS8-1G>C in DHCR7 and estimate of the expected incidence of Smith-Lemli-Opitz syndrome
5. Molecular genetics of the Smith-Lemli-Opitz syndrome and postsqualene sterol metabolism
6. 27 sterols by gas chromatography and mass spectrometry
7. Synthesis of ring B unsaturated estriols. Confirming the structure of a diagnostic analyte for Smith-Lemli-Opitz syndrome
8. Screening for abnormal cholesterol biosynthesis in the Smith-Lemli-Opitz syndrome: Rapid determination of plasma 7-dehydrocholesterol by ultraviolet spectrometry
9. Accurate detection of Smith-Lemli-Opitz syndrome carriers by measurement of the rate of reduction of the ergosterol C-7 double bond in cultured skin fibroblasts
10. Simvastatin. A new therapeutic approach for Smith-Lemli-Opitz syndrome
11. A rapid screening procedure for cholesterol and dehydrocholesterol by electrospray ionization tandem mass spectrometry
12. Standardization of serum cholesterol assays by use of serum calibrators and direct addition of Liebermann-Burchard reagent
13. Diagnosis of Smith-Lemli-Opitz syndrome by gas chromatography/mass spectrometry of 7-dehydrocholesterol in plasma, amniotic fluid and cultured skin fibroblasts
14. RSH/Smith-Lemli-Opitz syndrome: Mutations and metabolic morphogenesis
15. The Smith-Lemli-Opitz syndrome
16. Inborn errors of sterol biosynthesis
17. Prenatal diagnosis of the RSH/Smith-Lemli-Opitz syndrome
18. 7-cholesten-3β-ol
19. Cholesterol supplementation with egg yolk increases plasma cholesterol and decreases plasma 7-dehydrocholesterol in Smith-Lemli-Opitz syndrome
20. Borderline normal intelligence in the Smith-Lemli-Opitz (RSH) syndrome
21. 7-reductase activity in cultured human fibroblasts: A method for the diagnosis of Smith-Lemli-Opitz syndrome
22. Studies on the enzymatic conversion of 5α-cholesta-8,14-dien-3β-ol to cholesterol
23. Studies of the metabolism of 5α-cholesta-8,14-dien-3β-ol and 5α-cholesta-7,14-dien-3β-ol in rat liver homogenate preparations
24. Skin sterols. I. Colorimetric determination of cholesterol and other sterols in skin
25. Abnormal bile acids in the Smith-Lemli-Opitz syndrome
26. Smith-Lemli-Optiz syndrome and other sterol disorders among Finns with developmental disabilities
27. Difficult prenatal diagnosis in mild Smith-Lemli-Opitz syndrome
28. Frequency and ethnic distribution of the common DHCR7 mutation in Smith-Lemli-Opitz syndrome
29. RSH/Smith-Lemli-Opitz syndrome: A multiple congenital anomaly/mental retardation syndrome due to an inborn error of cholesterol biosynthesis
30. Sterols in blood of normal and Smith-Lemli-Opitz subjects
31. Smith-Lemli-Opitz syndrome: A variable clinical and biochemical phenotype
32. Quantification of 7-dehydrocholesterol in plasma and amniotic fluid by liquid chromatography/particle beam-mass spectrometry as a biochemical diagnostic marker for the Smith-Lemli-Opitz syndrome
33. Smith-Lemli-Opitz syndrome diagnosed by using time-of-flight secondary-ion mass spectrometry
34. Dehydro-oestriol and dehydropregnanetriol are candidate analytes for prenatal diagnosis of Smith-Lemli-Opitz syndrome
35. Direct determination of total serum cholesterol by use of double-wavelength spectrophotometry
36. Diagnosis of Smith-Lemli-Opitz syndrome from stored filter paper blood specimens
37. Defective cholesterol biosynthesis associated with the Smith-Lemli-Opitz syndrome
38. Fetal Smith-Lemli-Opitz syndrome can be detected accurately and reliably by measuring amniotic fluid dehydrocholesterols
39. The estimation of cholesterol in serum: A classification and critical review of methods
40. Biochemical and genetic aspects of 7-dehydrocholesterol reductase and Smith-Lemli-Opitz syndrome
41. 27 sterols by nuclear magnetic resonance spectroscopy
42. Frequency gradients of DHCR7 mutations in patients with Smith-Lemli-Opitz syndrome in Europe: Evidence for different origins of common mutations
43. Detection of a common mutation in the RSH or Smith-Lemli-Opitz syndrome by a PCR-RFLP assay: IVS8-G→C is found in over sixty percent of US propositi
44. Cholesterol methodology for human studies
45. Direct analysis of filter paper blood specimens for identification of Smith-Lemli-Opitz syndrome using time-of-flight secondary ion mass spectrometry
46. A review of reactions of some sterols in strongly acidic media